KOSDAQ · Healthcare · ₩2T
₩36,650+0.41%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 7.1% · as of 26.10.26
Among 97 제약 peers
Quarterly Revenue Growth
“제품 효율이 좋아져 매출보다 이익이 더 탄탄해졌어요.”
In the company's words · 2026 2분기 filing